John P Murad

Title: Innovations in Cancer Treatment by John P. Murad

Introduction

John P. Murad is a prominent inventor based in Diamond Bar, CA (US), known for his significant contributions to cancer treatment through innovative therapies. With a total of 2 patents, he has made strides in the field of immunotherapy, focusing on targeted treatments for various cancers.

Latest Patents

One of his latest patents is titled "TAG72 targeted chimeric antigen receptor modified T cells for treatment of TAG72-positive tumors." This patent describes chimeric antigen receptors that are specifically targeted to TAG72, which can be utilized to treat ovarian cancer and other related cancers. Another notable patent is "Membrane-bound IL-12 for cellular immunotherapy." This disclosure relates to cells that express both a chimeric antigen receptor (CAR) and membrane-bound IL-12, aimed at targeting and treating solid tumors and cancers that express specific markers such as CD19, CD22, BCMA, PSCA, HER2, and TAG-72.

Career Highlights

John P. Murad is associated with City of Hope, a leading research and treatment center for cancer, diabetes, and other life-threatening diseases. His work at this institution has been pivotal in advancing the understanding and treatment of cancer through innovative therapies.

Collaborations

He has collaborated with notable colleagues, including Saul J. Priceman and Stephen J. Forman, who share a commitment to improving cancer treatment through research and innovation.

Conclusion

John P. Murad's contributions to cancer treatment through his patents and work at City of Hope highlight the importance of innovation in the medical field. His efforts continue to pave the way for new therapeutic approaches that can significantly impact patient outcomes.